The EPA has proposed to rescind the 2009 decision that allowed it to regulate greenhouse gases as pollutants under the Clean Air Act.

The majority of patients with skin of color and scalp psoriasis who were treated with guselkumab achieved significant scalp clearance.

After adjusting for confounding factors, patients with CSU experience worse health outcomes and quality of life than patients with AD or PsO.

The UP-AA clinical program includes 2 studies assessing the safety and efficacy of upadacitinib in adults and adolescent patients with severe alopecia areata.

President Trump ordered the reinstatement of the Presidential Fitness Test program, which tests children's athletic abilities.

New research suggests that the survival benefits observed with different treatments for advanced melanoma vary according to the site of metastasis.

The FDA is updating opioid safety labels to support treatment decisions based on the latest evidence to reduce misuse.

A growing number of women with chronic inflammatory diseases are continuing to use TNF inhibitors throughout pregnancy.

More than half of pediatric patients with psoriasis or psoriasiform dermatitis had an anogenital or pharyngeal bacterial infection.

An increase in the population burden of atopic dermatitis was associated with increased levels of environmental pollution and weather extremes.

The FDA has granted Fast Track designation to rezpegaldesleukin for the treatment of severe to very severe alopecia areata.

Adding polygenic scores to early-life body mass index up to age 5 improved body mass index prediction at age 18 years.